EMD-104

N/A

Report date: 2025/01/26 19:12:28

Base Information

Drug NameEMD-104
Drug Alias Nameex vivo gene-transduced autologous hematopoietic stem cell-based gene therapy (Emendo Biotherapeutics/National Institute of Health)ex vivo gene-transduced autologous hematopoietic stem cell-based gene therapy (Emendo Biotherapeutics/National Institutes of Health)EMD-104
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBone Marrow Failure Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmendobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthEmendobio Inc
Inactive CompaniesN/A
Active IndicationsBone Marrow Failure Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A